148 related articles for article (PubMed ID: 25226534)
21. Inhibition of SAPK/JNK leads to enhanced IL-1-induced IL-6 synthesis in osteoblasts.
Kondo A; Otsuka T; Matsushima-Nishiwaki R; Kuroyanagi G; Mizutani J; Wada I; Kozawa O; Tokuda H
Arch Biochem Biophys; 2013 Jul; 535(2):227-33. PubMed ID: 23624146
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
24. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
25. IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase.
Kooijman R; Coppens A; Hooghe-Peters E
Cell Signal; 2003 Dec; 15(12):1091-8. PubMed ID: 14575864
[TBL] [Abstract][Full Text] [Related]
26. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways.
Gangoiti P; Granado MH; Wang SW; Kong JY; Steinbrecher UP; Gómez-Muñoz A
Cell Signal; 2008 Apr; 20(4):726-36. PubMed ID: 18234473
[TBL] [Abstract][Full Text] [Related]
27. c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.
Rush S; Khan G; Bamisaiye A; Bidwell P; Leaver HA; Rizzo MT
Exp Cell Res; 2007 Jan; 313(1):121-32. PubMed ID: 17055484
[TBL] [Abstract][Full Text] [Related]
28. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
Li M; Chiu JF; Gagne J; Fukagawa NK
J Cell Physiol; 2008 Nov; 217(2):377-87. PubMed ID: 18615585
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Molnar GA; Lindschau C; Dubrovska G; Mertens PR; Kirsch T; Quinkler M; Gollasch M; Wresche S; Luft FC; Muller DN; Fiebeler A
Hypertension; 2008 May; 51(5):1372-8. PubMed ID: 18347231
[TBL] [Abstract][Full Text] [Related]
31. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
[TBL] [Abstract][Full Text] [Related]
32. The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation.
Lin Y; Yang Q; Wang X; Liu ZG
J Biol Chem; 2006 Aug; 281(33):23525-32. PubMed ID: 16793775
[TBL] [Abstract][Full Text] [Related]
33. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
Allen RT; Krueger KD; Dhume A; Agrawal DK
Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
[TBL] [Abstract][Full Text] [Related]
34. Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase.
Cadalbert L; Sloss CM; Cameron P; Plevin R
Cell Signal; 2005 Oct; 17(10):1254-64. PubMed ID: 16038800
[TBL] [Abstract][Full Text] [Related]
35. Polymeric immunoglobulin receptor-mediated invasion of Streptococcus pneumoniae into host cells requires a coordinate signaling of SRC family of protein-tyrosine kinases, ERK, and c-Jun N-terminal kinase.
Agarwal V; Asmat TM; Dierdorf NI; Hauck CR; Hammerschmidt S
J Biol Chem; 2010 Nov; 285(46):35615-23. PubMed ID: 20829350
[TBL] [Abstract][Full Text] [Related]
36. SP600125 suppresses Cdk1 and induces endoreplication directly from G2 phase, independent of JNK inhibition.
Kim JA; Lee J; Margolis RL; Fotedar R
Oncogene; 2010 Mar; 29(11):1702-16. PubMed ID: 20062077
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.
Mobasher MA; González-Rodriguez A; Santamaría B; Ramos S; Martín MÁ; Goya L; Rada P; Letzig L; James LP; Cuadrado A; Martín-Pérez J; Simpson KJ; Muntané J; Valverde AM
Cell Death Dis; 2013 May; 4(5):e626. PubMed ID: 23661004
[TBL] [Abstract][Full Text] [Related]
38. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha-induced heat shock protein 27 in osteoblasts.
Tokuda H; Niwa M; Ishisaki A; Nakajima K; Ito H; Kato K; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):441-7. PubMed ID: 15062846
[TBL] [Abstract][Full Text] [Related]
39. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
40. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways.
Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S
Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
